Search Results - "Park, Inhae"

Crystal structure of dichlorobis(dimethylsulfoxide-O)-bis- (isonicotinic acid-N)copper(II)—dimethylsulfoxide (1:2), [CuCl2(C6H5NO2)2(C2H6OS)2]2 · 2C2H6OS by Kang Jaeun, Park Inhae, Kwak Youngbum, Jung Yeonsun, Kim Seonhong, Lee Yumi, Yun Hoseop, Do Junghwan

Get full text

Health Economic Analysis in Glaucoma by Park, Inhae, Gale, Jesse, Skalicky, Simon E.

“…The pressure on glaucoma services is ever-growing, and policymakers seek robust cost-effectiveness arguments in their decisions around resource allocation. The…”
Get full text

Happy campers? The relationships between leisure functioning, serious leisure, and happiness by Kim, Hyung Hoon, Park, Inhae, Bae, Jung-Sup

“…We examined the mediating role of serious leisure in the relationship between leisure functioning and happiness with data from 284 Korean campers, analyzed…”
Get full text

Abstract P5-16-03: Phase II study of trastuzumab biosimilar (Herzuma®) plus gedatolisib in patients with HER-2 positive metastatic breast cancer who progressed after 2 or more HER-2 directed chemotherapy (BR 18-13, KM-10A): Interim analysis by Kim, Ju Won, Ahn, Hee Kyung, Choi, Jong Gwon, Chae, Yee Soo, Lee, Gyeong-Won, Park, Keon Uk, Lee, Eunmi, Sim, Sung Hoon, Kim, Jee Hyun, Park, Yeon Hee, Kim, Miso, Park, Jin Hyun, Kim, Jeong Eun, Kim, Han Jo, Ahn, Mi Sun, Oh, So Yeon, Kim, Min Hwan, Koh, Su-Jin, Lee, Kyoung Eun, Kang, Myoung Joo, Byun, Jae Ho, Ha, Joo Young, Kwon, Jung Hye, Jung, Joo Young, Lee, Su Ee, Park, Inhae, Park, Kyong Hwa

“…Background: Prognosis of patients with HER-2 positive metastatic breast cancer (MBC) has been revolutionized with the development of monoclonal antibodies…”
Get full text

A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer by Nam, Seungyoon, Chang, Hae Ryung, Jung, Hae Rim, Gim, Youme, Kim, Nam Youl, Grailhe, Regis, Seo, Haeng Ran, Park, Hee Seo, Balch, Curt, Lee, Jinhyuk, Park, Inhae, Jung, So Youn, Jeong, Kyung-Chae, Powis, Garth, Liang, Han, Lee, Eun Sook, Ro, Jungsil, Kim, Yon Hui

“…Abstract Although trastuzumab is a successful targeted therapy for breast cancer patients with tumors expressing HER2 (ERBB2), many patients eventually…”
Get full text

Abstract GS01-12: MONARCH 3: Final overall survival results of abemaciclib plus a nonsteroidal aromatase inhibitor as first-line therapy for HR+, HER2- advanced breast cancer by Goetz, Matthew, Toi, Masakazu, Huober, Jens, Sohn, Joo Hyuk, Trédan, Olivier, Park, Inhae, Campone, Mario, Chen, Shin-Cheh, Manso, Luis Manual, Paluch-Shimon, Shani, Freedman, Orit C., Andre, Valerie, Saha, Abhijoy, van Hal, Gertjan, Shahir, Ashwin, Iwata, Hiroji, Johnston, Stephen RD, O'Shaughnessy, Joyce, Pivot, Xavier, Tolaney, Sara, Hurvitz, Sara, Llombart, Antonio

“…Background: Abemaciclib is approved both for high-risk early breast cancer as well as advanced breast cancer (ABC) in the first- and second-line setting. In…”
Get full text